{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:40:25Z","timestamp":1790260825113,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/leu.2016.175","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T08:46:42Z","timestamp":1467967602000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma"],"prefix":"10.1038","volume":"31","author":[{"given":"A","family":"Bouska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8502-6813","authenticated-orcid":false,"given":"Q","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Scuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Vose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ludvigsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D D","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T C","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"E","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Rimsza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Delabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E S","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Braziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-I","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"D\u2018Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T W","family":"McKeithan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W C","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"BFleu2016175_CR1","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","volume":"122","author":"R Kridel","year":"2012","unstructured":"Kridel R, Sehn LH, Gascoyne RD . Pathogenesis of follicular lymphoma. J Clin Invest 2012; 122: 3424\u20133431.","journal-title":"J Clin Invest"},{"key":"BFleu2016175_CR2","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-07-0456","volume":"13","author":"CW Ross","year":"2007","unstructured":"Ross CW, Ouillette PD, Saddler CM, Shedden KA, Malek SN . Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis. Clin Cancer Res 2007; 13: 4777\u20134785.","journal-title":"Clin Cancer Res"},{"key":"BFleu2016175_CR3","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.1158\/1078-0432.CCR-08-0752","volume":"14","author":"F d'Amore","year":"2008","unstructured":"d'Amore F, Chan E, Iqbal J, Geng H, Young K, Xiao L et al. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. Clin Cancer Res 2008; 14: 7180\u20137187.","journal-title":"Clin Cancer Res"},{"key":"BFleu2016175_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/gcc.10314","volume":"39","author":"M Hoglund","year":"2004","unstructured":"Hoglund M, Sehn L, Connors JM, Gascoyne RD, Siebert R, Sall T et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 2004; 39: 195\u2013204.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2016175_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/gcc.1103","volume":"30","author":"DE Horsman","year":"2001","unstructured":"Horsman DE, Connors JM, Pantzar T, Gascoyne RD . Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001; 30: 375\u2013382.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2016175_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/gcc.20780","volume":"49","author":"KJ Cheung","year":"2010","unstructured":"Cheung KJ, Delaney A, Ben-Neriah S, Schein J, Lee T, Shah SP et al. High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes. Genes Chromosomes Cancer 2010; 49: 669\u2013681.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2016175_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","volume":"123","author":"A Bouska","year":"2013","unstructured":"Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J et al. Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood 2013; 123: 1681\u20131690.","journal-title":"Blood"},{"key":"BFleu2016175_CR8","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","volume":"122","author":"C Bodor","year":"2013","unstructured":"Bodor C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K et al. EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 2013; 122: 3165\u20133168.","journal-title":"Blood"},{"key":"BFleu2016175_CR9","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","volume":"121","author":"MR Green","year":"2013","unstructured":"Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 2013; 121: 1604\u20131611.","journal-title":"Blood"},{"key":"BFleu2016175_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298\u2013303.","journal-title":"Nature"},{"key":"BFleu2016175_CR11","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1073\/pnas.1121343109","volume":"109","author":"JG Lohr","year":"2012","unstructured":"Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109: 3879\u20133884.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016175_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43: 830\u2013837.","journal-title":"Nat Genet"},{"key":"BFleu2016175_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012; 490: 116\u2013120.","journal-title":"Nature"},{"key":"BFleu2016175_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","volume":"46","author":"J Okosun","year":"2014","unstructured":"Okosun J, Bodor C, Wang J, Araf S, Yang CY, Pan C et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet 2014; 46: 176\u2013181.","journal-title":"Nat Genet"},{"key":"BFleu2016175_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","volume":"6","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB et al. Genetics of follicular lymphoma transformation. Cell Rep 2014; 6: 130\u2013140.","journal-title":"Cell Rep"},{"key":"BFleu2016175_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W Beguelin","year":"2013","unstructured":"Beguelin W, Popovic R, Teater M, Jiang Y, Bunting KL, Rosen M et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 2013; 23: 677\u2013692.","journal-title":"Cancer Cell"},{"key":"BFleu2016175_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.1032","volume":"44","author":"V Quesada","year":"2012","unstructured":"Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, Bassaganyas L et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012; 44: 47\u201352.","journal-title":"Nat Genet"},{"key":"BFleu2016175_CR18","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2016175_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","volume":"125","author":"M Yildiz","year":"2015","unstructured":"Yildiz M, Li H, Bernard D, Amin NA, Ouillette P, Jones S et al. Activating STAT6 mutations in follicular lymphoma. Blood 2015; 125: 668\u2013679.","journal-title":"Blood"},{"key":"BFleu2016175_CR20","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1182\/blood-2013-05-500264","volume":"123","author":"H Li","year":"2014","unstructured":"Li H, Kaminski MS, Li Y, Yildiz M, Ouillette P, Jones S et al. Mutations in linker histone genes HIST1H1 B, C, D and E, OCT2 (POU2F2), IRF8 and ARID1A underlying the pathogenesis of follicular lymphoma. Blood 2014; 123: 1487\u20131498.","journal-title":"Blood"},{"key":"BFleu2016175_CR21","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008; 359: 2313\u20132323.","journal-title":"N Engl J Med"},{"key":"BFleu2016175_CR22","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1073\/pnas.1732008100","volume":"100","author":"G Wright","year":"2003","unstructured":"Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM . A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9991\u20139996.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016175_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010; 463: 88\u201392.","journal-title":"Nature"},{"key":"BFleu2016175_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1126\/science.1153629","volume":"319","author":"G Lenz","year":"2008","unstructured":"Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 2008; 319: 1676\u20131679.","journal-title":"Science"},{"key":"BFleu2016175_CR25","doi-asserted-by":"publisher","first-page":"8240","DOI":"10.1021\/bi101052d","volume":"49","author":"RL Lamason","year":"2010","unstructured":"Lamason RL, McCully RR, Lew SM, Pomerantz JL . Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain. Biochemistry 2010; 49: 8240\u20138250.","journal-title":"Biochemistry"},{"key":"BFleu2016175_CR26","doi-asserted-by":"publisher","first-page":"e42775","DOI":"10.1371\/journal.pone.0042775","volume":"7","author":"S Li","year":"2012","unstructured":"Li S, Yang X, Shao J, Shen Y . Structural insights into the assembly of CARMA1 and BCL10. PLoS One 2012; 7: e42775.","journal-title":"PLoS One"},{"key":"BFleu2016175_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011; 470: 115\u2013119.","journal-title":"Nature"},{"key":"BFleu2016175_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.18632\/oncotarget.774","volume":"4","author":"B Schif","year":"2013","unstructured":"Schif B, Lennerz JK, Kohler CW, Bentink S, Kreuz M, Melzner I et al. SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients. Oncotarget 2013; 4: 35\u201347.","journal-title":"Oncotarget"},{"key":"BFleu2016175_CR29","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401\u20131414.","journal-title":"Cell"},{"key":"BFleu2016175_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cam4.29","volume":"1","author":"W Kwanhian","year":"2012","unstructured":"Kwanhian W, Lenze D, Alles J, Motsch N, Barth S, Doll C et al. MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Med 2012; 1: 141\u2013155.","journal-title":"Cancer Med"},{"key":"BFleu2016175_CR31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ni.2688","volume":"14","author":"CY Ying","year":"2013","unstructured":"Ying CY, Dominguez-Sola D, Fabi M, Lorenz IC, Hussein S, Bansal M et al. MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. Nat Immunol 2013; 14: 1084\u20131092.","journal-title":"Nat Immunol"},{"key":"BFleu2016175_CR32","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","volume":"122","author":"RD Morin","year":"2013","unstructured":"Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD et al. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood 2013; 122: 1256\u20131265.","journal-title":"Blood"},{"key":"BFleu2016175_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature13765","volume":"516","author":"JR Muppidi","year":"2014","unstructured":"Muppidi JR, Schmitz R, Green JA, Xiao W, Larsen AB, Braun SE et al. Loss of signalling via Galpha13 in germinal centre B-cell-derived lymphoma. Nature 2014; 516: 254\u2013258.","journal-title":"Nature"},{"key":"BFleu2016175_CR34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ni.2047","volume":"12","author":"JA Green","year":"2011","unstructured":"Green JA, Suzuki K, Cho B, Willison LD, Palmer D, Allen CD et al. The sphingosine 1-phosphate receptor S1P(2) maintains the homeostasis of germinal center B cells and promotes niche confinement. Nat Immunol 2011; 12: 672\u2013680.","journal-title":"Nat Immunol"},{"key":"BFleu2016175_CR35","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1158\/1078-0432.CCR-13-1597","volume":"20","author":"S Guo","year":"2014","unstructured":"Guo S, Chan JK, Iqbal J, McKeithan T, Fu K, Meng B et al. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations. Clin Cancer Res 2014; 20: 3078\u20133086.","journal-title":"Clin Cancer Res"},{"key":"BFleu2016175_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010; 42: 181\u2013185.","journal-title":"Nat Genet"},{"key":"BFleu2016175_CR37","doi-asserted-by":"publisher","first-page":"e28585","DOI":"10.1371\/journal.pone.0028585","volume":"6","author":"RJ Ryan","year":"2011","unstructured":"Ryan RJ, Nitta M, Borger D, Zukerberg LR, Ferry JA, Harris NL et al. EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas. PLoS One 2011; 6: e28585.","journal-title":"PLoS One"},{"key":"BFleu2016175_CR38","doi-asserted-by":"publisher","first-page":"13520","DOI":"10.1073\/pnas.0804295105","volume":"105","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008; 105: 13520\u201313525.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016175_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.immuni.2014.12.021","volume":"42","author":"OI Koues","year":"2015","unstructured":"Koues OI, Kowalewski RA, Chang LW, Pyfrom SC, Schmidt JA, Luo H et al. Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma. Immunity 2015; 42: 186\u2013198.","journal-title":"Immunity"},{"key":"BFleu2016175_CR40","doi-asserted-by":"publisher","first-page":"20753","DOI":"10.3390\/ijms151120753","volume":"15","author":"X Zheng","year":"2014","unstructured":"Zheng X, Liang Y, He Q, Yao R, Bao W, Bao L et al. Current models of mammalian target of rapamycin complex 1 (mTORC1) activation by growth factors and amino acids. Int J Mol Sci 2014; 15: 20753\u201320769.","journal-title":"Int J Mol Sci"},{"key":"BFleu2016175_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ng.3473","volume":"48","author":"J Okosun","year":"2015","unstructured":"Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM et al. Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nat Genet 2015; 48: 183\u2013188.","journal-title":"Nat Genet"},{"key":"BFleu2016175_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/bjh.12945","volume":"166","author":"TA Eyre","year":"2014","unstructured":"Eyre TA, Collins GP, Goldstone AH, Cwynarski K . Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies. Br J Haematol 2014; 166: 336\u2013351.","journal-title":"Br J Haematol"},{"key":"BFleu2016175_CR43","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1182\/blood-2007-04-087734","volume":"111","author":"BB Ding","year":"2008","unstructured":"Ding BB, Yu JJ, Yu RY, Mendez LM, Shaknovich R, Zhang Y et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 2008; 111: 1515\u20131523.","journal-title":"Blood"},{"key":"BFleu2016175_CR44","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/onc.2012.347","volume":"32","author":"W Vainchenker","year":"2013","unstructured":"Vainchenker W, Constantinescu SN . JAK\/STAT signaling in hematological malignancies. Oncogene 2013; 32: 2601\u20132613.","journal-title":"Oncogene"},{"key":"BFleu2016175_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/28101","volume":"394","author":"S Becker","year":"1998","unstructured":"Becker S, Groner B, Muller CW . Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998; 394: 145\u2013151.","journal-title":"Nature"},{"key":"BFleu2016175_CR46","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","volume":"120","author":"A Jerez","year":"2012","unstructured":"Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng Ng K et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 2012; 120: 3048\u20133057.","journal-title":"Blood"},{"key":"BFleu2016175_CR47","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1200\/JCO.2012.45.6004","volume":"31","author":"X Huang","year":"2013","unstructured":"Huang X, Meng B, Iqbal J, Ding BB, Perry AM, Cao W et al. Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 2013; 31: 4520\u20134528.","journal-title":"J Clin Oncol"},{"key":"BFleu2016175_CR48","doi-asserted-by":"publisher","first-page":"e55119","DOI":"10.1371\/journal.pone.0055119","volume":"8","author":"AH Shain","year":"2013","unstructured":"Shain AH, Pollack JR . The spectrum of SWI\/SNF mutations, ubiquitous in human cancers. PLoS One 2013; 8: e55119.","journal-title":"PLoS One"},{"key":"BFleu2016175_CR49","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/leu.2013.94","volume":"27","author":"X Zhao","year":"2013","unstructured":"Zhao X, Lwin T, Zhang X, Huang A, Wang J, Marquez VE et al. Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity. Leukemia 2013; 27: 2341\u20132350.","journal-title":"Leukemia"},{"key":"BFleu2016175_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4161\/epi.27957","volume":"9","author":"G Kuser-Abali","year":"2014","unstructured":"Kuser-Abali G, Alptekin A, Cinar B . Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression. Epigenetics 2014; 9: 634\u2013643.","journal-title":"Epigenetics"},{"key":"BFleu2016175_CR51","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ccr.2012.09.003","volume":"22","author":"X Zhang","year":"2012","unstructured":"Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R et al. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-cell lymphomas. Cancer Cell 2012; 22: 506\u2013523.","journal-title":"Cancer Cell"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2016175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016175","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:20:29Z","timestamp":1648743629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2016175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFleu2016175"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.175","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]},"assertion":[{"value":"10 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}